SCHEMBL23488686

SCHEMBL23488686

CO[C@@H]1O[C@H](COC(=O)c2cc(C)c(OCc3ccccc3)c(C)c2)[C@@H](O)[C@H](O)[C@H]1O

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.45
LMNA P02545 1/20 0.44
HPGD P15428 1/20 0.44
TYMP P19971 1/20 0.43
LGALS8 O00214 1/20 0.43
XDH P47989 2/20 0.42
SYNJ2 O15056 3/20 0.40
SLC5A1 P13866 2/20 0.39
SLC5A2 P31639 2/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
CA14 Q9ULX7 1/20 0.39
SLC22A1 O15245 1/20 0.38
TAOK1 Q7L7X3 1/20 0.38
TAOK3 Q9H2K8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23488299 0.89 TDP1 (0.44) TDP1LMNAHPGDTYMPLGALS8
SCHEMBL23488525 0.89 TDP1 (0.44) TDP1LMNAHPGDTYMPLGALS8
SCHEMBL23488175 0.89 TDP1 (0.44) TDP1LMNAHPGDTYMPLGALS8
SCHEMBL23488630 0.86 XDH (0.48) TDP1HPGDTYMPLGALS8XDH
SCHEMBL23488711 0.85 TDP1 (0.49) TDP1HPGDTYMPXDH
SCHEMBL23488297 0.85 TDP1 (0.48) TDP1TYMPLGALS8XDHSYNJ2
SCHEMBL23488568 0.85 TDP1 (0.47) TDP1LMNAHPGDTYMPLGALS8
SCHEMBL23488668 0.85 CHRNB2 (0.51) TDP1TYMPLGALS8XDHSYNJ2
SCHEMBL23488128 0.85 CHRNB2 (0.51) TDP1TYMPLGALS8XDHSYNJ2
SCHEMBL23488262 0.85 CHRNB2 (0.51) TDP1TYMPLGALS8XDHSYNJ2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN SANOFI (FR) 2021-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN GPR119, SLC2A8, SLC2A4 TDP1 4093/4885LMNA 4539/4885HPGD 4318/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.